Drug Device Combination Products Market Size Worth $343.59 Billion by 2034 | CAGR: 8.8%

The global drug device combination products market size is expected to reach USD 343.59 billion by 2034, according to a new study by Polaris Market Research. The report “Drug Device Combination Products Market Size, Share, Trends, Industry Analysis Report, By Type (Drug Eluting Stents, Infusion Pumps, Inhalers, Orthopedic Combination Products, Wound Care Combination Products, Photodynamic Therapy Devices, Transdermal Patches, Antimicrobial Catheters, and Others), Application, End user, and Region-Market Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising geriatric population across the globe is driving the global drug device combination products market. Elderly individuals commonly have several chronic ailments like diabetes, hypertension, and arthritis. Drug-device combination products that combine medication delivery with monitoring or other supportive functions are especially advantageous for addressing these intricate health requirements, thus increasing the need. Thus, the growing geriatric population is expanding the market. For instance,

According to a report published by the United Nations, the number of people aged 65 years or older worldwide is projected to more than double, rising from 761 million in 2021 to 1.6 billion in 2050.

The global market for drug-device combination products is being fueled by the rising incidence of diabetes. Managing diabetes involves continuous medication and monitoring. Drug-device combination products, like insulin pumps or continuous glucose monitors (CGMs), streamline diabetes management by integrating drug delivery and monitoring into one device, increasing convenience for the patient and thereby boosting demand.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/drug-device-combination-products-market/request-for-sample

The rising investments in drug delivery activities are propelling the global drug device combination products market. Companies in the market are able to create products that cater to specific medical needs and deliver better performance than current solutions with increased investment. This drives the need for more advanced and up-to-date drug delivery devices.

Drug Device Combination Products Market Report Highlights

• The transdermal patches segment dominated the market share in 2024 due to their non-invasive nature, which aligns with the rising demand for minimally invasive and patient-friendly drug delivery solutions.
• Drug eluting stents segment is anticipated to witness the highest growth over the study period, due to their effectiveness in treating coronary artery disease by releasing medications that prevent restenosis of the artery.
• Cardiovascular disorders segment accounted for the largest market share in 2024, owing to the critical need for advanced technologies for managing coronary artery disease and heart failure.
• North America dominated the market in 2024 due to the advanced healthcare infrastructure, high levels of research and development activity, and strong regulatory frameworks that support innovation and market entry. Additionally, the presence of numerous leading pharmaceutical and medical device companies contributed to the segment's dominance.
• Asia Pacific is projected to register the fastest growth over the study period, attributable to the expanding healthcare sector, increasing investments in medical technology, and rising patient populations.
• The global players include Abbott; Becton, Dickinson and Company; Boston Scientific Corporation; Medtronic; Novartis AG; Sensely, Inc.; Stryker; Teleflex Incorporated; Terumo Medical Corporation; Viatris Inc.; and Hovione.

Polaris Market Research has segmented the drug device combination products market report based on type, application, End user, and region.

By Type Outlook (Revenue - USD Billion, 2020 - 2034)

• Drug Eluting Stents
• Infusion Pumps
• Inhalers
• Orthopedic Combination Products
• Wound Care Combination Products
• Photodynamic Therapy Devices
• Transdermal Patches
• Antimicrobial Catheters
• Others

By Application Outlook (Revenue - USD Billion, 2020 - 2034)

• Cardiovascular Disorder
• Diabetes
• Respiratory Problems
• Cancer Treatment
• Others

By End user Outlook (Revenue - USD Billion, 2020 - 2034)

• Hospitals
• Ambulatory Surgical Centers
• Others

    By Regional Outlook (Revenue - USD Billion, 2020 - 2034)

• North America

• US
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe

• Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of Asia Pacific

• Latin America

• Argentina
• Brazil
• Mexico
• Rest of Latin America

• Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa

Drug Device Combination Products Market Report Scope